Informations:
Erreur:
ID
33291
Description
Vernakalant Versus Flecainide: Atrial Contractility; ODM derived from: https://clinicaltrials.gov/show/NCT01646281
Lien
https://clinicaltrials.gov/show/NCT01646281
Mots-clés
Versions (1)
- 04/12/2018 04/12/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
4 décembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Atrial Fibrillation NCT01646281
Eligibility Atrial Fibrillation NCT01646281
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT01646281
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Persistent atrial fibrillation | Paroxysmal atrial fibrillation
Item
persistent af or paroxysmal af
boolean
C2585653 (UMLS CUI [1])
C0235480 (UMLS CUI [2])
C0235480 (UMLS CUI [2])
Vernakalant Infusion | Flecainide Infusion | Sinus rhythm Restore
Item
eligible for treatment with vernakalant or flecainide infusion to restore sinus rhythm
boolean
C2001572 (UMLS CUI [1,1])
C0574032 (UMLS CUI [1,2])
C0016229 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C0232201 (UMLS CUI [3,1])
C1283255 (UMLS CUI [3,2])
C0574032 (UMLS CUI [1,2])
C0016229 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C0232201 (UMLS CUI [3,1])
C1283255 (UMLS CUI [3,2])
Anticoagulant therapy | Atrial Fibrillation Episode Duration
Item
receiving adequate anticoagulant therapy (or having an episode of af lasting < 24 hours)
boolean
C0150457 (UMLS CUI [1])
C0004238 (UMLS CUI [2,1])
C0332189 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0004238 (UMLS CUI [2,1])
C0332189 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Informed Consent Refused | Informed Consent Unable
Item
refusal or inability to give informed consent to participate in this study
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C1705116 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Atrial Flutter
Item
atrial flutter
boolean
C0004239 (UMLS CUI [1])
Medical contraindication Vernakalant | Medical contraindication Flecainide
Item
contra-indications for receiving vernakalant or flecainide according to mumc+
boolean
C1301624 (UMLS CUI [1,1])
C2001572 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0016229 (UMLS CUI [2,2])
C2001572 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0016229 (UMLS CUI [2,2])
Hemodynamic instability | LVEF | Potassium level Inadequate | Ischemia | Sinus Node Dysfunction
Item
protocol (unstable hemodynamic condition, lvef < 40%, inadequate potassium levels, acute ischaemia, sinus node dysfunction)
boolean
C0948268 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
C0202194 (UMLS CUI [3,1])
C0205412 (UMLS CUI [3,2])
C0022116 (UMLS CUI [4])
C0428908 (UMLS CUI [5])
C0428772 (UMLS CUI [2])
C0202194 (UMLS CUI [3,1])
C0205412 (UMLS CUI [3,2])
C0022116 (UMLS CUI [4])
C0428908 (UMLS CUI [5])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])